This section contains two parts. The first part includes references to documents, related weblinks and existing toolkits regarding behavioural surveillance methodology and evaluation methods in the HIV/AIDS field.
On 9 June, ECDC will be hosting a technical side-event to the United Nations High-Level Meeting on AIDS 2011. The event will highlight how countries and regions with differing epidemiology could improve their responses to HIV/AIDS.
Heightened surveillance of acute febrile illness in China since 2009 has led to the identification of a severe fever with thrombocytopenia syndrome (SFTS).
ECDC Director Marc Sprenger at the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) stressed the importance of the EU’s continuous commitment in the fight against hepatitis B and hepatitis C.
Tick-borne zoonoses (TBZ) are emerging diseases worldwide. A large amount of information (e.g. case reports, results of epidemiological surveillance, etc.) is dispersed through various reference sources (ISI and non-ISI journals, conference proceedings, technical reports, etc.).
Experimental and Applied Acarology 2011 Jan 12; [Epub ahead of print]The distribution of the meadow tick, Dermacentor reticulatus (Fabricius) is divided into two separate areas-Western Europe and Eastern (Russian).
A dynamic population model of Hyalomma marginatum, the vector of several pathogens in the western Palearctic, was developed to simulate effects of temperature and water vapour deficit (VD) on tick survival, development rates and seasonality.
The European network for arthropod vector surveillance for human public health (VBORNET), funded by the European Centre for Disease Prevention and Control, holds its second annual general meeting at the Institute of Tropical Medicine in Antwerp, Belgium, on 18-20 April 2011
The first annual meeting of the European hepatitis B and C surveillance network takes place on 23-24 March 2011. Since 2009, ECDC has worked on preparing the enhanced surveillance of hepatitis B and C at EU/EEA level by establishing a network for hepatitis B and C surveillance and by carrying out a survey on prevention and surveillance activities in the Member States.